Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Harpoon Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Harpoon Therapeutics Inc 52 week high is $23.01 as of September 10, 2025.
What is the 52-week low for Harpoon Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Harpoon Therapeutics Inc 52 week low is $23.01 as of September 10, 2025.
What is Harpoon Therapeutics Inc stock price today?
Harpoon Therapeutics Inc stock price today is $23.01.
What was Harpoon Therapeutics Inc stock price yesterday?
Harpoon Therapeutics Inc stock price yesterday was $22.99.
What is the 50-day moving average of Harpoon Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Harpoon Therapeutics Inc 50-day moving average is $23.01.